BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37739109)

  • 1. Excess body weight and postmenopausal breast cancer: Emerging molecular mechanisms and perspectives.
    Nahmias-Blank D; Maimon O; Meirovitz A; Sheva K; Peretz-Yablonski T; Elkin M
    Semin Cancer Biol; 2023 Nov; 96():26-35. PubMed ID: 37739109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial polyps in obese asymptomatic pre and postmenopausal patients with breast cancer: is screening necessary?
    Lubián López DM; Orihuela López F; García-Berbel Molina L; Boza Novo P; Pozuelo Solís E; Menor Almagro D; Comino Delgado R
    Gynecol Oncol; 2014 Apr; 133(1):56-62. PubMed ID: 24680592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium.
    Bandera EV; Chandran U; Hong CC; Troester MA; Bethea TN; Adams-Campbell LL; Haiman CA; Park SY; Olshan AF; Ambrosone CB; Palmer JR; Rosenberg L
    Breast Cancer Res Treat; 2015 Apr; 150(3):655-66. PubMed ID: 25809092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between menopausal status and obesity in affecting breast cancer risk.
    Rose DP; Vona-Davis L
    Maturitas; 2010 May; 66(1):33-8. PubMed ID: 20181446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of breast cancer subtypes and body mass index.
    Petekkaya I; Sahin U; Gezgen G; Solak M; Yuce D; Dizdar O; Arslan C; Ayyildiz V; Altundag K
    Tumori; 2013; 99(2):129-33. PubMed ID: 23748802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women.
    Rosner B; Eliassen AH; Toriola AT; Hankinson SE; Willett WC; Natarajan L; Colditz GA
    Breast Cancer Res Treat; 2015 Apr; 150(3):643-53. PubMed ID: 25796612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
    Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
    Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
    Ritte R; Lukanova A; Berrino F; Dossus L; Tjønneland A; Olsen A; Overvad TF; Overvad K; Clavel-Chapelon F; Fournier A; Fagherazzi G; Rohrmann S; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Panico S; Tumino R; Vineis P; Quirós JR; Buckland G; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Sund M; Lenner P; Bueno-de-Mesquita B; van Gils CH; Peeters PH; Krum-Hansen S; Gram IT; Lund E; Khaw KT; Wareham N; Allen NE; Key TJ; Romieu I; Rinaldi S; Siddiq A; Cox D; Riboli E; Kaaks R
    Breast Cancer Res; 2012 May; 14(3):R76. PubMed ID: 22583394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression.
    Bhardwaj P; Au CC; Benito-Martin A; Ladumor H; Oshchepkova S; Moges R; Brown KA
    J Steroid Biochem Mol Biol; 2019 May; 189():161-170. PubMed ID: 30851382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
    Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
    JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity, mammography use and accuracy, and advanced breast cancer risk.
    Kerlikowske K; Walker R; Miglioretti DL; Desai A; Ballard-Barbash R; Buist DS
    J Natl Cancer Inst; 2008 Dec; 100(23):1724-33. PubMed ID: 19033562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Obesity and the Risk of Breast Cancer among Pre and Postmenopausal Women.
    Gravena AAF; Romeiro Lopes TC; Demitto MO; Borghesan DHP; Dell’ Agnolo CM; Brischiliari SCR; Carvalho MDB; Pelloso SM
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2429-2436. PubMed ID: 30255696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study.
    Harvie M; Howell A; Vierkant RA; Kumar N; Cerhan JR; Kelemen LE; Folsom AR; Sellers TA
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):656-61. PubMed ID: 15767346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
    Wang SM; Pfeiffer RM; Gierach GL; Falk RT
    Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophages Upregulate Estrogen Receptor Expression in the Model of Obesity-Associated Breast Carcinoma.
    Nahmias Blank D; Hermano E; Sonnenblick A; Maimon O; Rubinstein AM; Drai E; Maly B; Vlodavsky I; Popovtzer A; Peretz T; Meirovitz A; Elkin M
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity, estrogen production, and tumor estrogen receptors in women with carcinoma of the breast.
    Donegan WL; Johnstone MF; Biedrzycki L
    Am J Clin Oncol; 1983 Feb; 6(1):19-24. PubMed ID: 6837504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype.
    Shieh Y; Scott CG; Jensen MR; Norman AD; Bertrand KA; Pankratz VS; Brandt KR; Visscher DW; Shepherd JA; Tamimi RM; Vachon CM; Kerlikowske K
    Breast Cancer Res; 2019 Apr; 21(1):48. PubMed ID: 30944014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
    Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women.
    Crispo A; Montella M; Buono G; Grimaldi M; D'Aiuto M; Capasso I; Esposito E; Amore A; Nocerino F; Augustin LS; Giudice A; Di Bonito M; Giuliano M; Forestieri V; De Laurentiis M; Rinaldo M; Ciliberto G; De Placido S; Arpino G
    Curr Res Transl Med; 2016; 64(1):15-20. PubMed ID: 27140595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.